• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Bears, beets, rifaximin.熊、甜菜、利福昔明。
Can Liver J. 2021 Nov 11;4(4):438-442. doi: 10.3138/canlivj-2021-0026. eCollection 2021 Fall.
2
The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial.利福昔明在经颈静脉肝内门体分流术后预防显性肝性脑病中的应用：一项随机对照试验。
Ann Intern Med. 2021 May;174(5):633-640. doi: 10.7326/M20-0202. Epub 2021 Feb 2.
3
Rifaximin for the treatment of hepatic encephalopathy.利福昔明用于治疗肝性脑病。
Transplant Proc. 2010 Dec;42(10):4543-7. doi: 10.1016/j.transproceed.2010.09.173.
4
Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy.利福昔明联合乳果糖与单用乳果糖治疗肝性脑病的比较。
J Assoc Physicians India. 2017 Aug;65(8):42-46.
5
Rifaximin treatment in hepatic encephalopathy.利福昔明治疗肝性脑病。
N Engl J Med. 2010 Mar 25;362(12):1071-81. doi: 10.1056/NEJMoa0907893.
6
Rifaximin for the treatment of hepatic encephalopathy.利福昔明用于治疗肝性脑病。
Pharmacotherapy. 2008 Aug;28(8):1019-32. doi: 10.1592/phco.28.8.1019.
7
Rifaximin versus nonabsorbable disaccharides in the management of hepatic encephalopathy: a meta-analysis.利福昔明与不可吸收双糖治疗肝性脑病的Meta分析
Eur J Gastroenterol Hepatol. 2008 Nov;20(11):1064-70. doi: 10.1097/MEG.0b013e328302f470.
8
Efficacy of Switching from Kanamycin Sulfate to Rifaximin in Patients with Hepatic Cirrhosis.硫酸卡那霉素换用利福昔明治疗肝硬化的疗效。
Intern Med. 2021 May 15;60(10):1501-1507. doi: 10.2169/internalmedicine.6039-20. Epub 2020 Dec 22.
9
The cost-effectiveness and budget impact of competing therapies in hepatic encephalopathy - a decision analysis.肝性脑病中竞争性疗法的成本效益和预算影响——一项决策分析
Aliment Pharmacol Ther. 2007 Oct 15;26(8):1147-61. doi: 10.1111/j.1365-2036.2007.03464.x.
10
Rifaximin, a nonabsorbed oral antibiotic, in the treatment of hepatic encephalopathy: antimicrobial activity, efficacy, and safety.利福昔明，一种口服不吸收的抗生素，用于治疗肝性脑病：抗菌活性、疗效及安全性
Rev Gastroenterol Disord. 2005;5 Suppl 1:S10-8.

本文引用的文献

1
The Use of Rifaximin in the Prevention of Overt Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt : A Randomized Controlled Trial.利福昔明在经颈静脉肝内门体分流术后预防显性肝性脑病中的应用：一项随机对照试验。
Ann Intern Med. 2021 May;174(5):633-640. doi: 10.7326/M20-0202. Epub 2021 Feb 2.
2
Primary prophylaxis of hepatic encephalopathy in decompensated cirrhosis: Low dose vs. full dose rifaximin.失代偿期肝硬化患者肝性脑病的一级预防：低剂量与全剂量利福昔明对比
Pak J Med Sci. 2019 Sep-Oct;35(5):1446-1450. doi: 10.12669/pjms.35.5.549.
3
Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.门静脉高压领域共识的拓展：巴韦诺VI共识研讨会报告：门静脉高压风险分层与个体化治疗
J Hepatol. 2015 Sep;63(3):743-52. doi: 10.1016/j.jhep.2015.05.022. Epub 2015 Jun 3.
4
Rifaximin: beyond the traditional antibiotic activity.利福昔明：超越传统抗生素活性。
J Antibiot (Tokyo). 2014 Sep;67(9):667-70. doi: 10.1038/ja.2014.106. Epub 2014 Aug 6.
5
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.慢性肝病中的肝性脑病：美国肝病研究协会和欧洲肝脏研究协会2014年实践指南
Hepatology. 2014 Aug;60(2):715-35. doi: 10.1002/hep.27210. Epub 2014 Jul 8.
6
TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis.经颈静脉肝内门体分流术可提高肝硬化难治性腹水患者无肝移植生存期：一项更新的荟萃分析。
World J Gastroenterol. 2014 Mar 14;20(10):2704-14. doi: 10.3748/wjg.v20.i10.2704.
7
Rifaximin treatment in hepatic encephalopathy.利福昔明治疗肝性脑病。
N Engl J Med. 2010 Mar 25;362(12):1071-81. doi: 10.1056/NEJMoa0907893.
8
Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases.利福昔明：一种用于治疗肠道疾病的胃肠道选择性抗生素。
Curr Opin Gastroenterol. 2010 Jan;26(1):17-25. doi: 10.1097/MOG.0b013e328333dc8d.
9
Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study.经颈静脉肝内门体分流术后肝性脑病的药物预防：一项随机对照研究
J Hepatol. 2005 May;42(5):674-9. doi: 10.1016/j.jhep.2004.12.028.
10
Comparison of rifaximin and lactitol in the treatment of acute hepatic encephalopathy: results of a randomized, double-blind, double-dummy, controlled clinical trial.利福昔明与乳梨醇治疗急性肝性脑病的比较：一项随机、双盲、双模拟、对照临床试验的结果
J Hepatol. 2003 Jan;38(1):51-8. doi: 10.1016/s0168-8278(02)00350-1.

Bears, beets, rifaximin.

作者信息

Wang Peter L, Flemming Jennifer A

机构信息

Department of Medicine, Queen's University, Kingston, Ontario, Canada.

Department of Public Health Sciences, Queen's University, Kingston, Ontario, Canada.

出版信息

Can Liver J. 2021 Nov 11;4(4):438-442. doi: 10.3138/canlivj-2021-0026. eCollection 2021 Fall.

DOI:10.3138/canlivj-2021-0026
PMID:35989893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9235125/
Abstract
摘要